Paper41328404
Dual Regulation and Clinical Application of miR-34 in Virus-Related Tumors Through Anti-Viral Immunity and Tumor Suppression.
Pan Y and 4 others. Drug Des Devel Ther, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Dual Regulation and Clinical Application of miR-34 in Virus-Related Tumors Through Anti-Viral Immunity and Tumor Suppression. Papers, record 41328404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41328404
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dual Regulation and Clinical Application of miR-34 in Virus-Related Tumors Through Anti-Viral Immunity and Tumor Suppression.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Neoplasms | Major topic |
| Antineoplastic Agents | Major topic |
| Virus Diseases | Major topic |
| Antiviral Agents | Major topic |
| Humans | |
| Animals |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31199581 | MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/31199581 | PubMed |
| 2 | 40119810 | Macrophage-Mediated Delivery of miR-34a-5p-Nanoparticles for Pathogenic Inhibition of Kaposi's Sarcoma-Associated Herpesvirus. | J Med Virol | 2025 | https://conductscience.org/library/papers/40119810 | PubMed |
| 3 | 36829591 | miR-34b/c-5p/CXCL10 Axis Induced by RSV Infection Mediates a Mechanism of Airway Hyperresponsive Diseases. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/36829591 | PubMed |
| 4 | 27580334 | Use of Flaviviral genetic fragments as a potential prevention strategy for HIV-1 Silencing. | J Infect Dev Ctries | 2016 | https://conductscience.org/library/papers/27580334 | PubMed |
| 5 | 33398678 | A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines. | Mol Biol Rep | 2021 | https://conductscience.org/library/papers/33398678 | PubMed |
| 6 | 30637720 | The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30637720 | PubMed |
| 7 | 30717802 | MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30717802 | PubMed |
| 8 | 32357442 | High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32357442 | PubMed |
| 9 | 27610823 | MicroRNA 34a contributes to virus-mediated apoptosis through binding to its target gene Bax in influenza A virus infection. | Biomed Pharmacother | 2016 | https://conductscience.org/library/papers/27610823 | PubMed |
| 10 | 34541575 | The Importance of miRNA Identification During Respiratory Viral Infections. | J Cell Immunol | 2021 | https://conductscience.org/library/papers/34541575 | PubMed |
| 11 | 32238921 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. | Br J Cancer | 2020 | https://conductscience.org/library/papers/32238921 | PubMed |
| 12 | 34503302 | Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503302 | PubMed |
| 13 | 36939771 | Recent Progresses in Electrochemical DNA Biosensors for MicroRNA Detection. | Phenomics | 2022 | https://conductscience.org/library/papers/36939771 | PubMed |
| 14 | 33614246 | miRNA in food simultaneously controls animal viral disease and human tumorigenesis. | Mol Ther Nucleic Acids | 2021 | https://conductscience.org/library/papers/33614246 | PubMed |
| 15 | 38013231 | The ethanolic extract of Corylus avellana L. drives a microRNA-based cytotoxic effect on HepG2 hepatocarcinoma cells. | Nat Prod Res | 2025 | https://conductscience.org/library/papers/38013231 | PubMed |
| 16 | 30679313 | The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression. | J Biol Chem | 2019 | https://conductscience.org/library/papers/30679313 | PubMed |
| 17 | 33112434 | Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis. | APMIS | 2021 | https://conductscience.org/library/papers/33112434 | PubMed |
| 18 | 38885278 | Wolbachia mediates crosstalk between miRNA and Toll pathways to enhance resistance to dengue virus in Aedes aegypti. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/38885278 | PubMed |
| 19 | 39773049 | miR-34 as a Critical Regulator in Ovarian Cancer. | Curr Mol Med | 2025 | https://conductscience.org/library/papers/39773049 | PubMed |
| 20 | 35444864 | miR-34a-5p inhibits the malignant progression of KSHV-infected SH-SY5Y cells by targeting c-fos. | PeerJ | 2022 | https://conductscience.org/library/papers/35444864 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| IRF3 | 3661 | PubTator's text mining | https://conductscience.org/library/genes/3661 | NCBI Gene |
| MIR34A | 407040 | PubTator's text mining | https://conductscience.org/library/genes/407040 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41328404
GET https://conductscience.org/api/papers/v1/41328404/references?page=2